Artivion (AORT) vs Alpha Tau Medical (DRTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Tau Medical (DRTS) has outperformed Artivion (AORT) over the past year, gaining 245.0% versus a loss of 46.7%. Over five years, DRTS leads with a +44.1% price change compared with +1.2% for AORT. Alpha Tau Medical is the larger company by market cap ($1.32 billion vs $1.05 billion), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | DRTS |
|---|---|---|
| Share price | $21.61 | $14.25 |
| Market cap | $1.05B | $1.32B |
| 1-day change | -1.05% | -1.59% |
| YTD return | -52.62% | +187.88% |
| 1-year return | -46.66% | +245.04% |
| 5-year return | +1.17% | +44.08% |
| Forward P/E | 28.88 | — |
| EPS (TTM) | $-0.07 | $-1.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.25 | $15.79 |
| 52-week low | $19.16 | $3.43 |
| Distance from 52-week high | -55.21% | -9.75% |
| Analyst consensus | none | none |
| Avg. price target upside | +95.05% | +24.91% |
| Average volume | 639.01K | 568.24K |
| Shares outstanding | 48.76M | 92.48M |
| Employees | 1,800 | 121 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DRTS has outperformed AORT by 291.7 percentage points over the past year.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Healthcare · Medical Devices · 1,800 employees
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Healthcare · Biotechnology · 121 employees
AORT vs DRTS FAQ
Which is bigger, Artivion or Alpha Tau Medical?
Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.32B compared with $1.05B for Artivion (AORT).
Which stock has performed better over the past year, AORT or DRTS?
DRTS returned +245.04% over the past 12 months, compared with -46.66% for AORT (price return, excluding dividends). Past performance does not predict future results.
Are Artivion and Alpha Tau Medical in the same industry?
Both are in the Healthcare sector, but in different industries: Medical Devices for Artivion and Biotechnology for Alpha Tau Medical.